Impact BioMedical, Inc. (IBO)
3.55
-0.18
(-4.83%)
USD |
NYAM |
Oct 27, 16:00
3.50
-0.05
(-1.41%)
After-Hours: 20:00
Impact BioMedical Price : 3.55 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 3.78 | 4.11 | 3.55 | 3.55 | 12270.00 |
| Oct 26, 2026 | 3.74 | 3.88 | 3.10 | 3.73 | 12613.00 |
| Oct 23, 2026 | 3.69 | 4.020 | 3.54 | 3.60 | 11828.00 |
| Oct 22, 2026 | 3.82 | 4.23 | 3.60 | 3.80 | 21553.00 |
| Oct 21, 2026 | 3.60 | 4.32 | 3.60 | 4.02 | 27681.00 |
| Oct 20, 2026 | 2.78 | 3.42 | 2.674 | 3.268 | 12335.00 |
| Oct 19, 2026 | 2.66 | 3.75 | 2.66 | 3.06 | 47951.00 |
| Oct 16, 2026 | 3.21 | 3.21 | 2.43 | 2.68 | 10214.00 |
| Oct 15, 2026 | 3.17 | 4.08 | 2.62 | 3.158 | 29041.00 |
| Oct 14, 2026 | 3.59 | 3.85 | 3.250 | 3.403 | 3967.00 |
| Oct 13, 2026 | 4.11 | 4.11 | 3.84 | 3.98 | 9476.00 |
| Oct 12, 2026 | 4.25 | 4.46 | 4.00 | 4.03 | 7387.00 |
| Oct 09, 2026 | 4.13 | 4.39 | 4.13 | 4.25 | 4029.00 |
| Oct 08, 2026 | 4.32 | 4.41 | 4.06 | 4.11 | 17561.00 |
| Oct 07, 2026 | 4.57 | 4.59 | 4.36 | 4.48 | 10739.00 |
| Oct 06, 2026 | 5.00 | 5.05 | 4.43 | 4.68 | 21172.00 |
| Oct 05, 2026 | 5.16 | 5.42 | 4.84 | 4.84 | 17339.00 |
| Oct 02, 2026 | 5.54 | 5.54 | 5.265 | 5.320 | 11554.00 |
| Oct 01, 2026 | 5.88 | 5.88 | 5.43 | 5.43 | 8991.00 |
| Sep 30, 2026 | 5.48 | 5.75 | 5.48 | 5.60 | 3927.00 |
| Sep 29, 2026 | 5.50 | 6.17 | 5.43 | 5.60 | 9044.00 |
| Sep 28, 2026 | 5.69 | 6.023 | 5.590 | 5.61 | 9266.00 |
| Sep 25, 2026 | 5.80 | 6.500 | 5.58 | 5.69 | 20646.00 |
| Sep 24, 2026 | 6.86 | 6.86 | 5.51 | 5.65 | 23370.00 |
| Sep 23, 2026 | 6.46 | 7.11 | 5.62 | 6.63 | 40516.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| LENZ Therapeutics, Inc. | 3.15 |
| Enveric Biosciences, Inc. | 1.42 |
| ANI Pharmaceuticals, Inc. | 71.17 |
| Corcept Therapeutics, Inc. | 87.59 |
| Veru, Inc. | 2.28 |
Price Related Metrics
| PS Ratio | 667.91 |
| Price to Book Value | 2.817 |
| Earnings Yield | -34.92% |
| Market Cap | 30.33M |